KANNALIFE Trademark

Trademark Overview


On Monday, August 12, 2013, a trademark application was filed for KANNALIFE with the United States Patent and Trademark Office. The USPTO has given the KANNALIFE trademark a serial number of 86034690. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, May 11, 2015. This trademark is owned by KannaLife Sciences, Inc.. The KANNALIFE trademark is filed in the Chemical Products, Pharmaceutical Products, and Computer & Software Services & Scientific Services categories with the following description:

Active chemical ingredients for use in the manufacture of pharmaceuticals for treating Oxidative Stress Related and Neurodegenerative Diseases; Chemical additives for use in the manufacture of naturopathic and/or pharmaceutical products for the treatment of Oxidative Stress Related and Neurodegenerative Diseases; Emollient used as an ingredient in the manufacture of cosmetics, toiletries, and pharmaceuticals

Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Homeopathic pharmaceuticals for use in the treatment of Oxidative Stress Related and Neurodegenerative Diseases; Inhalers filled with naturopathic and/or pharmaceutical products for the treatment of Oxidative Stress Related and Neurodegenerative Diseases; Pharmaceutical agents affecting digestive organs; Pharmaceutical agents affecting metabolism; Pharmaceutical agents affecting peripheral nervous system; Pharmaceutical agents for epidermis; Pharmaceutical for the treatment of erectile dysfunction; Pharmaceutical preparation for skin care; Pharmaceutical preparation for the treatment of gout; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations and substances for ...

Conducting early evaluations in the field of new pharmaceuticals; Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Development of pharmaceutical preparations and medicines; Laboratory research services relating to pharmaceuticals; Pharmaceutical products development; Pharmaceutical research and development; Research and development in the pharmaceutical and biotechnology fields; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Research in the field of Oxidative Stress Related and Neurodegenerative Diseases
kannalife

General Information


Serial Number86034690
Word MarkKANNALIFE
Filing DateMonday, August 12, 2013
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, May 11, 2015
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 12, 2014

Trademark Statements


Goods and ServicesActive chemical ingredients for use in the manufacture of pharmaceuticals for treating Oxidative Stress Related and Neurodegenerative Diseases; Chemical additives for use in the manufacture of naturopathic and/or pharmaceutical products for the treatment of Oxidative Stress Related and Neurodegenerative Diseases; Emollient used as an ingredient in the manufacture of cosmetics, toiletries, and pharmaceuticals
Goods and ServicesDrug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Homeopathic pharmaceuticals for use in the treatment of Oxidative Stress Related and Neurodegenerative Diseases; Inhalers filled with naturopathic and/or pharmaceutical products for the treatment of Oxidative Stress Related and Neurodegenerative Diseases; Pharmaceutical agents affecting digestive organs; Pharmaceutical agents affecting metabolism; Pharmaceutical agents affecting peripheral nervous system; Pharmaceutical agents for epidermis; Pharmaceutical for the treatment of erectile dysfunction; Pharmaceutical preparation for skin care; Pharmaceutical preparation for the treatment of gout; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of psychiatric diseases and disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for animal skincare; Pharmaceutical preparations for peripheral nervous system; Pharmaceutical preparations for skin care; Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; for the treatment of inflammatory disorders; for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Pharmaceutical preparations for the prevention of Oxidative Stress Related and Neurodegenerative Diseases; Pharmaceutical preparations for the treatment and prevention of Oxidative Stress Related and Neurodegenerative Diseases; Pharmaceutical preparations for the treatment of Oxidative Stress Related and Neurodegenerative Diseases; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations for the treatment of Oxidative Stress Related and Neurodegenerative Diseases; Pharmaceutical preparations, namely, elixirs for the treatment of Oxidative Stress Related and Neurodegenerative Diseases; Pharmaceutical products and preparations to prevent swelling in the legs; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical skin lotions; Pharmaceuticals for the treatment of erectile dysfunction; Pharmaceuticals, namely, inducers of erections; Pharmaceuticals, namely, psychotropics; Plant extracts for medical, veterinary and pharmaceutical purposes; Sunburn preparations for pharmaceutical purposes; Syringes sold filled with naturopathic and/or pharmaceutical products for the treatment of Oxidative Stress Related and Neurodegenerative Diseases; Syrups for pharmaceutical purposes for the treatment of Oxidative Stress Related and Neurodegenerative Diseases; Therapeutic pharmaceutical for the treatment of Oxidative Stress Related and Neurodegenerative Diseases
Goods and ServicesConducting early evaluations in the field of new pharmaceuticals; Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Development of pharmaceutical preparations and medicines; Laboratory research services relating to pharmaceuticals; Pharmaceutical products development; Pharmaceutical research and development; Research and development in the pharmaceutical and biotechnology fields; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Research in the field of Oxidative Stress Related and Neurodegenerative Diseases
Pseudo MarkKANNA LIFE

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateTuesday, August 20, 2013
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, August 20, 2013
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, August 20, 2013
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameKannaLife Sciences, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWest Hills, NY 11743

Party NameKannaLife Sciences, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWest Hills, NY 11743

Trademark Events


Event DateEvent Description
Monday, May 11, 2015ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, May 11, 2015ABANDONMENT - NO USE STATEMENT FILED
Tuesday, October 7, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, August 13, 2014ASSIGNED TO EXAMINER
Tuesday, August 12, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 12, 2014PUBLISHED FOR OPPOSITION
Monday, August 11, 2014ASSIGNED TO EXAMINER
Wednesday, July 23, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 8, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, July 7, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, June 10, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, June 10, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, June 4, 2014ASSIGNED TO LIE
Wednesday, May 21, 2014TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, November 27, 2013NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, November 27, 2013NON-FINAL ACTION E-MAILED
Wednesday, November 27, 2013NON-FINAL ACTION WRITTEN
Wednesday, November 27, 2013ASSIGNED TO EXAMINER
Wednesday, August 21, 2013NOTICE OF PSEUDO MARK E-MAILED
Tuesday, August 20, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, August 15, 2013NEW APPLICATION ENTERED IN TRAM